Can systemic inflammation contribute to insomnia symptoms?

Systemic inflammation is increasingly recognized as a central factor in the development and persistence of insomnia. This relationship is governed by a bidirectional pathway where inflammation compromises sleep quality, while sleep loss subsequently intensifies inflammatory signaling.

Clinical and effectiveness evidence

Research consistently links elevated systemic markers with poor sleep outcomes. High-sensitivity C-reactive protein (hs-CRP) and the systemic immune-inflammation index (SII) are significantly associated with subjective and objective insomnia symptoms. Longitudinal data indicate that persistent insomnia is correlated with sustained serum CRP levels. Furthermore, cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) are elevated following sleep debt, with their levels predicting self-reported sleep quality and affective reactivity.

Mechanistic explanations

Inflammatory signaling disrupts sleep through several distinct pathways:

• Hyperarousal and Neurotransmitter Imbalance: Pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) cross the blood-brain barrier and modulate neural circuits. They upregulate excitatory glutamatergic signaling and the kynurenine pathway while downregulating inhibitory GABAergic transmission. This shift creates neuronal hyperexcitability, reflected in increased EEG beta power and reduced heart rate variability (HRV).
• Disruption of Sleep Homeostasis: While some cytokines (IL-1β, TNF-α) act as sleep-regulatory substances that promote NREM sleep, chronic elevation leads to pathological outcomes. Persistent inflammatory signaling activates the NLRP3 inflammasome in the cortex and increases NREM at the expense of REM sleep, causing significant sleep fragmentation.
• Circadian Misalignment: Cytokines interfere with the molecular clock by inhibiting BMAL1-CLK complexes and modulating rhythms in the suprachiasmatic nucleus (SCN). This suppresses wake-promoting centers and leads to circadian misalignment.
• Neuroendocrine Activation: Inflammation sensitizes the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS), creating a feed-forward loop that maintains a state of physiological alert.

Bottom line

The claim is strongly supported by evidence showing that systemic inflammation creates a state of physiological hyperarousal and disrupts the brain's homeostatic and circadian sleep regulation. High levels of circulating cytokines (IL-1β, IL-6, TNF-α) drive insomnia symptoms by altering the balance between excitatory and inhibitory neurotransmitters and fragmenting sleep architecture.